Meihua
Large-scale joint venture integrating research, development and production.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
| CNY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 34 % | 22 % | (1 %) | (10 %) | 12 % | 8 % | 6 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 20 % | 24 % | 19 % | 19 % | 18 % | 18 % | 18 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 10 % | 16 % | 11 % | 11 % | 11 % | 11 % | 12 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 1 % | 1 % | 1 % | 2 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Meihua Holdings Group Co., Ltd. is a publicly traded bio-fermentation company based in China, specializing in amino acids. The company's journey began as a family-run food stall called "Yuxin Food," founded by Mr. Meng Qingshan and his family in Hebei. This modest venture evolved into a wholesale business centered on supplying monosodium glutamate (MSG). Officially established as Hebei Meihua Monosodium Glutamate Group in April 2002 by Meng Qingshan, Yang Weiyong, and Hu Jijun, the company quickly scaled its operations.
By 2006, Meihua had established major production bases in Hebei and Inner Mongolia. A significant milestone occurred in late 2010 when the company was listed on the Shanghai Stock Exchange (stock code 600873) after a shareholding reform and acquisition of a shell company in 2009. The current chairman is Wang Aijun. The group operates major production facilities in regions including Inner Mongolia, Xinjiang, and Jilin. Headquartered in Langfang, Hebei, the company has grown into a significant player in the global bio-fermentation industry.
Meihua's business model is centered on the large-scale production and sale of a wide range of amino acid products derived from processing raw materials like corn. Revenue is generated from two primary business segments: animal nutrition and food flavorings. The company serves a global client base across more than 150 countries, spanning industries such as food additives, feed additives, and pharmaceutical intermediates. Their product portfolio is extensive, including animal nutrition amino acids like lysine and threonine, food flavor enhancers such as MSG and nucleotides, and pharmaceutical-grade amino acids like glutamine and proline. They also produce colloidal polysaccharides, such as xanthan gum, and various bulk by-products. The animal nutrition amino acids segment has become a primary revenue driver, accounting for 53% of total revenue in 2022.
Keywords: amino acids, bio-fermentation, food additives, animal nutrition, monosodium glutamate, flavor enhancers, pharmaceutical intermediates, lysine, threonine, xanthan gum, publicly traded, Shanghai Stock Exchange, 600873, Meng Qingshan, Wang Aijun, agricultural processing, corn processing, biotechnology, food ingredients, feed additives
